Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis

Brain Research Bulletin

Volumn 69, Issue 3, 2006, Pages 327-331

  Tajouri, Lotti ^a   Martin, Virginie ^a   Gasparini, Claudia ^a   Ovcaric, Micky ^a   Curtain, Rob ^a   Lea, Rod A ^a,d   Haupt, Larisa M ^a   Csurhes, Peter ^b,c   Pender, Michael P ^b,c   Griffiths, Lyn R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

Author keywords

COMT; Gene association; Homocysteine; MTHFR; Multiple sclerosis; Polymorphism

Indexed keywords

CATECHOL METHYLTRANSFERASE; DNA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ARTICLE; AUSTRALIA; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CHI-SQUARE DISTRIBUTION; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MULTIPLE SCLEROSIS; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33645069644     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2006.01.005     Document Type: Article

References (27)

1. E. Akesson, A. Oturai, J. Berg, S. Fredrikson, O. Andersen, H.F. Harbo, M. Laaksonen, K.M. Myhr, H.I. Nyland, L.P. Ryder, M. Sandberg-Wollheim, P.S. Sorensen, A. Spurkland, A. Svejgaard, P. Holmans, A. Compston, J. Hillert, and S. Sawcer A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis Genes Immun. 3 5 2002 279 285
2. J. De Keyser, E. Zeinstra, and N. Wilczak Astrocytic beta2-adrenergic receptors and multiple sclerosis Neurobiol. Dis. 15 2 2004 331 339
3. J. Ekblom, S.M. Aquilonius, and S.S. Jossan Differential increases in catecholamine metabolizing enzymes in amyotrophic lateral sclerosis Exp. Neurol. 123 2 1993 289 294
4. D.L. Feinstein, M.T. Heneka, V. Gavrilyuk, C. Dello Russo, G. Weinberg, and E. Galea Noradrenergic regulation of inflammatory gene expression in brain Neurochem. Int. 2002 41 5 2002 357 365
5. E.M. Frohman, B. Vayuvegula, S. Gupta, and N.S. Van den Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanisms Proc. Natl. Acad. Sci. U. S. A. 85 1988 1292 1296
6. E.M. Frohman, B. Vayuvegula, N.S. Van den, and S. Gupta Norepinephrine inhibits gamma-interferon-induced MHC class II (Ia) antigen expression on cultured brain astrocytes J. Neuroimmunol. 17 1998 89 101
7. P. Frosst, H.J. Blom, R. Milos, P. Goyette, C.A. Sheppard, R.G. Mathews, G.J. Boers, M. Den Heijer, L.A. Kluijtamas, L.P. Van den Heuvel, and R. Rozen A candidate genetic risk factor for vascular disease. A common mutation in methylenetetrahydrofolate reductase Nat. Genet. 10 1995 111 113
8. R. Goertsches, P. Villoslada, M. Comabella, X. Montalban, A. Navarro, E.G. de la Concha, R. Arroyo, A. Lopez de Munain, D. Otaegui, R. Palacios, J. Perez-Tur, A. Jonasdottir, K. Benediktsson, R. Fossdal, S. Sawcer, E. Setakis, and A. Compston A genomic screen of Spanish multiple sclerosis patients reveals multiple loci associated with the disease J. Neuroimmunol. 43 1/2 2003 124 128
9. P. Goyette, J.S. Summer, R. Milos, A.M. Ducan, D.S. Rosenblatt, R.G. Matthews, and R. Rozen Human methylenetetrahydrofolate reductase isolation of cDNA, mapping and mutation identification Nat. Genet. 7 1994 195 200
10. H.T. Besler, and S. Comoglu Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis Nutr. Neurosci. 6 3 2003 189 196
11. B. Hemmer, J.J. Archelos, and H. Hartung New concepts in the immunopathogenesis of multiple sclerosis Nat. Rev. Neurosci. 3 2002 291 301
12. K. Hirano, T. Ogihara, M. Miki, H. Yasuda, H. Tamai, N. Kawamura, and M. Mino Homocysteine induces iron-catalyzed lipid peroxidation of low-density lipoprotein that is prevented by alpha-tocopherol Free Radic. Res. 21 1994 267 276
13. A. Jonasdottir, T. Thorlacius, R. Fossdal, A. Jonasdottir, K. Benediktsson, J. Benedikz, H.H. Jonsson, J. Sainz, H. Einarsdottir, S. Sigurdardottir, G. Kristjansdottir, S. Sawcer, A. Compston, K. Stefansson, and J. Gulcher A whole genome association study in Icelandic multiple sclerosis patients with 4804 markers J. Neuroimmunol. 143 1/2 2003 88 92
14. K. Kohara, M. Fujisawa, F. Ando, Y. Tabara, N. Niino, T. Miki, and H. Shimokata NILS-LSA study, MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: the NILS-LSA study Stroke 34 5 2003 1130 1135
15. I.I. Kruman, C. Culmsee, S.L. Chan, Y. Kruman, Z. Guo, L. Penix, and M.P. Mattson Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity J. Neurosci. 20 2000 6920 6926
16. H.M. Lachman, D.F. Papolos, T. Saito, Y.M. Yu, C.L. Szumlanski, and R.M. Weinshilboum Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders Pharmacogenetics 6 1996 243 250
17. H. Lassmann, F. Zimprich, K. Rossler, and K. Vass Inflammation in the nervous system. Basic mechanisms and immunological concepts Rev. Neurol. 147 1991 763 781
18. C. Loder, J. Allawi, and D.F. Horrobin Treatment of multiple sclerosis with lofepramine, l-phenylalanine and vitamin B(12): mechanism of action and clinical importance: roles of the locus coeruleus and central noradrenergic systems Med. Hypotheses 59 5 2002 594 602
19. M.B. Mann, S. Wu, M. Rostamkhani, W.W. Tourtellotte, J.P. MacMurray, and D.E. Comings Association between the phenylethanolamine N-methyltransferase gene and multiple sclerosis J. Neuroimmunol. 124 1/2 2002 101 105
20. A. Mohamed, A. Shoker, F. Bendjelloul, A. Mare, M. Alzrigh, H. Benghuzzi, and T. Desin Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor Biomed. Sci. Instrum. 39 2003 440 445
21. Multiple Sclerosis Genetics Group A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex Nat. Genet. 13 1996 469 471
22. K. Nakaso, K. Yasui, H. Kowa, M. Kusumi, K. Ueda, Y. Yoshimoto, T. Takeshima, K. Sasaki, and K. Nakashima Hypertrophy of IMC of carotid artery in Parkinson's disease is associated with L-DOPA, homocysteine, and MTHFR genotype J. Neurol. Sci. 207 2003 19 23
23. D.S. Rosenblatt Inherited disorders of folate transport and metabolism C.R. Scriver AL. Beaudet W.S. Sly D. Vall The Metabolic Basis of Inherited Disease 7th ed. 1995 McGraw-Hill New York 3111 3128
24. F.L. Sciacca, E. Ciusani, A. Silvani, E. Corsini, S. Frigerio, S. Pogliani, E. Parati, D. Croci, A. Boiardi, and A. Salmaggi Genetic and plasma markers of venous thromboembolism in patients with high grade glioma Clin. Cancer Res. 10 4 2004 1312 1317
25. S. Shifman, M. Bronstein, M. Sternfeld, A. Pisante-Shalom, E. Lev-Lehman, A. Weizman, I. Reznik, B. Spivak, N. Grisaru, L. Karp, R. Schiffer, M. Kotler, R.D. Strous, M. Swartz-Vanetik, H.Y. Knobler, E. Shinar, J.S. Beckmann, B. Yakir, N. Risch, N.B. Zak, and A. Darvasi A highly significant association between a COMT haplotype and schizophrenia Am. J. Hum. Genet. 71 2002 1296 1302
26. L. Tajouri, V. Martin, M. Ovcaric, R.P. Curtain, R.A. Lea, P. Csurhes, M.P. Pender, and L.R. Griffiths Investigation of an inducible nitric oxide synthase gene (NOS2A) polymorphism in a multiple sclerosis population Brain Res. Bull. 64 1 2004 9 13
27. P.K. Toshniwal, and E.J. Zarling Evidence for increased lipid peroxidation in multiple sclerosis Neurochem. Res. 17 1992 205 207